Jinhe

Jinhe Biotechnology is a prominent global player in the animal health sector, recognized as the world's largest manufacturer of chlortetracycline (CTC) feed additives. Headquartered in Inner Mongolia, China, the company specializes in the research, development, and large-scale production of veterinary pharmaceuticals, biological products, and animal nutrition solutions. Its product portfolio includes a wide range of antibiotics, ionophore coccidiostats, and an expanding line of veterinary vaccines targeting major livestock diseases such as Swine Reproductive and Respiratory Syndrome. The company operates state-of-the-art fermentation and manufacturing facilities that comply with international GMP standards, enabling it to export products to over 50 countries, including the United States. Publicly traded on the Shenzhen Stock Exchange, Jinhe Biotechnology continues to invest in innovation through its dedicated R&D centers and collaborations with leading agricultural universities.